First Wave BioPharma Provides Update on Adrulipase (FW-EPI) Clinical Program
January 13, 2022 07:00 ET
|
First Wave BioPharma, Inc.
Company filed two provisional patent applications for new enteric granule formulation of adrulipase and for related nutritional indications in new patient populations “Adrulipase Alfa” approved by...